Discover 129 paid clinical trials in Fort Smith, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 129
Active & Responsive
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
for
Non Small Cell Lung Cancer,
Location: Fort Smith AR, Joplin MO, Springfield MO,
Sponsor: PrECOG, LLC.
Sex: All
Age: 18+
Code: NCT06538038
Recruiting
Active & Responsive
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
for
Colorectal Cancer
Location: Fort Smith AR, Joplin MO, Springfield MO,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05234177
Recruiting
Active & Responsive
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
for
Plasma Cell Myeloma
Location: Fort Smith AR, Branson MO, Joplin MO, Little Rock AR,
Sponsor: SWOG Cancer Research Network
Sex: All
Age: 0+
Code: NCT05561387
Phase3, Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: Fayetteville AR, Little Rock AR, Columbia MO,
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Candida Therapeutic Vaccine in Head and Neck Cancer Patients to Reduce Recurrence
Location: Springdale AR, Pittsburgh PA, New York NY
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase2, Recruiting
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
for
Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma,
Location: Fort Smith AR, Branson MO, Joplin MO, Little Rock AR,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT04566328
Phase3, Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
for
Anatomic Stage II Breast Cancer AJCC v8,
Location: Fort Smith AR, Little Rock AR, Springfield MO,